Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP34 activates NFkappaB. 3 / 3

| 3

➶

reach

"We present evidence that knockdown of Ubiquitin Specific Protease 34 (USP34) selectively enhanced NF-kappaB activation driven by TCR engagement, similarly to siRNA against the well characterized DUB cylindromatosis (CYLD)."

23590831

➶

reach

"Hence, our results suggest that USP34 likely functions downstream of the CBM-IKK nexus to enhance NF-kappaB activation."

23590831

➶

reach

"Combined, these results indicate that USP34 shares some functional similarities with CYLD and selectively targets the NF-kappaB signaling pathway."

23590831

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

USP34 activates NFkappaB. 3 / 3

Our Sources:

Databases

Reading